- Added to Email Alerts
Rare Diseases
Latest News & Journal Articles View All
-
US FDA Declines Full Approval for Intercept's Liver Disease Drug
-
AlertFDA Approves Obe-cel for ALL -
Botulism Outbreaks in Europe Raise Food Safety Concerns -
US FDA Declines to Approve Camurus' Rare Hormone Disorder Drug
-
Radiotherapy Cuts Myeloma Risk in Rare Head and Neck Cancer -
US FDA Approves IntraBio's Drug for Rare Genetic Disease
-
Zevra Therapeutics Prices Rare Genetic Disorder Drug At Up to $106,000 Per Month
-
AlertHympavzi Recommended for Approval in Europe for Severe Hemophilia A, B
